InvaGen Pharmaceuticals, Inc. - 10%+ Owner at Avenue Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
ATXI on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by InvaGen Pharmaceuticals, Inc. since 12/23/2023

Holdings reported by InvaGen Pharmaceuticals, Inc. for Avenue Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.0001 per share 0 Oct 11, 2022 Direct
Common Stock, par value $0.0001 per share 0 Oct 11, 2022 Indirect

Transactions reported by InvaGen Pharmaceuticals, Inc. for Avenue Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.